OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ICL$1874.0058

ICL.TA

Agricultural ChemicalsVerified

ICL.TA maintains a capital structure with a debt-to-equity ratio of 0.46, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with cash and equivalents of $291 million and a current ratio of 1.33, suggesting limited short-term liquidity cushion relative to its obligations. Despite a positive operating cash flow of $1.06 billion, the company reported negative free cash flow of $111 million, driven by capital expenditures of $824 million. Profitability metrics for ICL.TA show a return on equity (ROE) of 3.78% and a return on assets (ROA) of 1.82%, both below the industry median for Agricultural Chemicals. The company's net income of $226 million is supported by an operating income of $580 million, but its gross profit margin of 30.56% (calculated from $2.19 billion gross profit on $7.15 billion revenue) is also below the industry median. Geographically, ICL.TA derives the majority of its revenue from the Middle East and North Africa (MENA) region, with a significant portion also coming from Europe and the Americas. The company's revenue concentration in the MENA region exposes it to geopolitical and regulatory risks, particularly in light of ongoing tensions in the region. Looking ahead, ICL.TA is projected to see a modest growth in revenue, with a current FY outlook of 2.1% and a next FY outlook of 3.4%. These growth rates are in line with the industry median but reflect a cautious approach due to macroeconomic headwinds and input cost volatility. The company faces several risk factors, including liquidity constraints and the potential for dilution. The risk assessment indicates a low probability of dilution in the near term, but the company's negative net cash position (after subtracting total debt) raises concerns about its ability to fund operations and capital expenditures without external financing. Additionally, the company's high price-to-book ratio of 404.27 and price-to-earnings ratio of 10,702.3 suggest that the market is pricing in significant future growth expectations, which may not materialize. Recent events, including the company's 2023 annual report and investor presentations, highlight ongoing efforts to optimize its global production footprint and reduce costs. The company has also been investing in sustainability initiatives, including the development of low-carbon fertilizers and water treatment solutions.

30-day price · ICL+250.00 (+15.2%)
Low$1535.00High$2008.00Close$1900.00As of28 May, 00:00 UTC
Profile
CompanyICL.TA
TickerICL.TA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Israel Chemicals Ltd (ICL.TA) is a global leader in the production and distribution of specialty minerals and agricultural solutions, including potash, phosphates, and nitrogen fertilizers, and serves the agriculture, food, and industrial markets.

Classification. ICL.TA is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a confidence level of 0.92 based on verified market data.

ICL.TA maintains a capital structure with a debt-to-equity ratio of 0.46, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with cash and equivalents of $291 million and a current ratio of 1.33, suggesting limited short-term liquidity cushion relative to its obligations. Despite a positive operating cash flow of $1.06 billion, the company reported negative free cash flow of $111 million, driven by capital expenditures of $824 million. Profitability metrics for ICL.TA show a return on equity (ROE) of 3.78% and a return on assets (ROA) of 1.82%, both below the industry median for Agricultural Chemicals. The company's net income of $226 million is supported by an operating income of $580 million, but its gross profit margin of 30.56% (calculated from $2.19 billion gross profit on $7.15 billion revenue) is also below the industry median. Geographically, ICL.TA derives the majority of its revenue from the Middle East and North Africa (MENA) region, with a significant portion also coming from Europe and the Americas. The company's revenue concentration in the MENA region exposes it to geopolitical and regulatory risks, particularly in light of ongoing tensions in the region. Looking ahead, ICL.TA is projected to see a modest growth in revenue, with a current FY outlook of 2.1% and a next FY outlook of 3.4%. These growth rates are in line with the industry median but reflect a cautious approach due to macroeconomic headwinds and input cost volatility. The company faces several risk factors, including liquidity constraints and the potential for dilution. The risk assessment indicates a low probability of dilution in the near term, but the company's negative net cash position (after subtracting total debt) raises concerns about its ability to fund operations and capital expenditures without external financing. Additionally, the company's high price-to-book ratio of 404.27 and price-to-earnings ratio of 10,702.3 suggest that the market is pricing in significant future growth expectations, which may not materialize. Recent events, including the company's 2023 annual report and investor presentations, highlight ongoing efforts to optimize its global production footprint and reduce costs. The company has also been investing in sustainability initiatives, including the development of low-carbon fertilizers and water treatment solutions.
Key takeaways
  • ICL.TA has a moderate debt-to-equity ratio of 0.46, but its free cash flow is negative due to high capital expenditures.
  • The company's profitability metrics (ROE and ROA) are below the industry median, indicating subpar returns.
  • ICL.TA is heavily exposed to the MENA region, which introduces geopolitical and regulatory risks.
  • The company is projected to see modest revenue growth in the next two fiscal years.
  • ICL.TA faces liquidity constraints and a high valuation multiple, which may not be justified by its current performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$7.15B
Gross profit$2.19B
Operating income$580.0M
Net income$226.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.06B
CapEx-$824.0M
Free cash flow-$111.0M
Total assets$12.41B
Total liabilities$6.43B
Total equity$5.98B
Cash & equivalents$291.0M
Long-term debt$2.76B
Valuation
Market price$1874.00
Market cap$2.42T
Enterprise value$2.42T
P/E10702.3
Reported non-GAAP P/E
EV/Revenue338.5
EV/Op income4174.5
EV/OCF2292.8
P/B404.3
P/Tangible book404.3
Tangible book$5.98B
Net cash-$2.46B
Current ratio1.3
Debt/Equity0.5
ROA1.8%
ROE3.8%
Cash conversion4.7%
CapEx/Revenue-11.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricICLActivity
Op margin8.1%5.5% medp25 -0.0% · p75 10.8%above median
Net margin3.2%4.1% medp25 0.1% · p75 8.8%below median
Gross margin30.6%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-11.5%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity46.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target6.44 USD
Median price target6.44 USD
High price target6.89 USD
Low price target6.00 USD
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.41 USD
Last actual EPS0.36 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 16:50 UTC#1299b442
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 04:31 UTCJob: 2898cc99